macular retinal edema
macular retinal edema
Explore linked clinical trials. Standard reference: MONDO:000300530 results · Page 1 of 2
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-005) | Diabetes Complications, cardiovascular disorder, diabetes mellitus, diabetic peripheral angiopathy, diabetic retinopathy, endocrine system disorder, eye disorder, macular degeneration, macular retinal edema, retinal degeneration, retinal disorder, vascular disorder | Recruiting | Phase 3 | 2026-10-09 | NCT07705607 | |
| A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-004) | Diabetes Complications, cardiovascular disorder, diabetes mellitus, diabetic peripheral angiopathy, diabetic retinopathy, endocrine system disorder, eye disorder, macular degeneration, macular retinal edema, retinal degeneration, retinal disorder, vascular disorder | Recruiting | Phase 3 | 2026-10-09 | NCT07705555 | |
| OCT Macula Biomarkers Before Silicone Oil Removal and Visual Outcome After Silicone Oil Removal | eye disorder, macular degeneration, macular retinal edema, preretinal fibrosis, retinal degeneration, retinal detachment, retinal disorder | Not yet recruiting | Not stated | 2026-10-08 | NCT07865468 | |
| A Study to Test Whether BI 1815368 Helps People With an Eye Condition Called Diabetic Macular Edema | eye disorder, macular degeneration, macular retinal edema, retinal degeneration, retinal disorder | Recruiting | Phase 2 | 2026-10-01 | NCT06962839 | |
| MIND-AMD Study: a Multidisciplinary Investigation of Neuroretinal Damage in Age-related Macular Degeneration. | eye disorder, macular degeneration, macular retinal edema, retinal degeneration, retinal disorder | Not yet recruiting | Not stated | 2026-09-29 | NCT07847151 | |
| Safety, Tolerability and Efficacy of Intravitreal KIO-104 in Patients With Macular Edema | eye disorder, macular degeneration, macular retinal edema, retinal degeneration, retinal disorder | Recruiting | Phase 2 | 2026-09-09 | NCT06825702 | |
| Video Intervention to Improve Understanding of Diabetic Retinopathy at Zuckerberg San Francisco General Hospital and Trauma Center | Diabetes Complications, Nutritional and Metabolic Diseases, cardiovascular disorder, diabetes mellitus, diabetic peripheral angiopathy, diabetic retinopathy, endocrine system disorder, eye disorder, glucose metabolism disease, macular degeneration, macular retinal edema, metabolic disease, retinal degeneration, retinal disorder, vascular disorder | Not yet recruiting | Not applicable | 2026-07-22 | NCT07519707 | |
| Evaluating the Safety and Tolerability of Orally Administered DF-003 in ROSAH Syndrome Patients | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Hereditary, cone-rod dystrophy, eye disorder, hereditary disease, inherited retinal dystrophy, macular degeneration, macular retinal edema, retinal degeneration, retinal disorder, retinal dystrophy, optic nerve edema, splenomegaly, anhidrosis, and migraine headache syndrome, uveal disorder, uveitis | Recruiting | Phase 1 | 2026-06-05 | NCT06395285 | |
| A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PINNACLE | eye disorder, macular degeneration, macular retinal edema, retinal degeneration, retinal disorder | Recruiting | Phase 3 | 2026-05-18 | NCT06996080 | |
| A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PEAK | eye disorder, macular degeneration, macular retinal edema, retinal degeneration, retinal disorder | Recruiting | Phase 3 | 2026-05-18 | NCT06990399 | |
| Mecobalamin Combined With Anti-VEGF Intravitreal Injection for Retinal Vein Occlusion Treatment | Embolism and Thrombosis, Venous Thrombosis, cardiovascular disorder, eye disorder, macular degeneration, macular retinal edema, retinal degeneration, retinal disorder, retinal vein occlusion, thrombotic disease, vascular disorder | Recruiting | Phase 4 | 2026-02-27 | NCT07133438 | |
| Therapeutic Contact Lens Drug Delivery System (TCL-DDS) in Patients With Recurrent Cystoid Macular Edema | eye disorder, macular degeneration, macular retinal edema, retinal degeneration, retinal disorder | Recruiting | Phase 1 / Phase 2 | 2025-11-26 | NCT04225611 | |
| High Resolution, High-speed Multimodal Ophthalmic Imaging | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Hereditary, Nutritional and Metabolic Diseases, age-related macular degeneration, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, corneal disorder, corneal dystrophy, diabetes mellitus, dry eye syndrome, endocrine system disorder, eye disorder, glaucoma, glucose metabolism disease, hereditary disease, hypertensive disorder, inherited retinal dystrophy, injury, keratoconus, lacrimal apparatus disorder, macular degeneration, macular retinal edema, metabolic disease, nervous system disorder, ocular hypertension, retinal degeneration, retinal detachment, retinal disorder, retinitis pigmentosa, stroke disorder, vascular disorder | Recruiting | Not applicable | 2025-11-18 | NCT04129021 | |
| Effect of Levosulpiride on Retinal Alterations in Patients With Diabetic Retinopathy and Diabetic Macular Edema | Diabetes Complications, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Sensation Disorders, Signs and Symptoms, blindness (disorder), cardiovascular disorder, diabetes mellitus, diabetic macular edema, diabetic peripheral angiopathy, diabetic retinopathy, endocrine system disorder, eye disorder, macular degeneration, macular retinal edema, nervous system disorder, retinal degeneration, retinal disorder, vascular disorder, vision disorder | Recruiting | Phase 2 | 2025-11-18 | NCT03161652 | |
| Imaging Retinal Vasculature in Infant Eyes | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases and Pregnancy Complications, Infant, Newborn, Diseases, Infant, Premature, Diseases, Obstetric Labor Complications, Obstetric Labor, Premature, Premature Birth, Urogenital Diseases, eye disorder, macular degeneration, macular retinal edema, pregnancy disorder, retinal degeneration, retinal disorder, retinopathy of prematurity | Recruiting | Not stated | 2025-10-06 | NCT05558059 | |
| MS-553 in Diabetic Retinopathy Patients With Central Involved Macular Edema | Diabetes Complications, cardiovascular disorder, diabetes mellitus, diabetic macular edema, diabetic peripheral angiopathy, diabetic retinopathy, endocrine system disorder, eye disorder, macular degeneration, macular retinal edema, retinal degeneration, retinal disorder, vascular disorder | Recruiting | Phase 1 | 2025-09-29 | NCT04187443 | |
| Comparing Efficacy of Bromfenac 0.09%, Nepafenac 0.3% and Diclofenac 0.1% in Patients After Cataract Surgery | eye disorder, macular degeneration, macular retinal edema, retinal degeneration, retinal disorder | Recruiting | Not applicable | 2025-09-17 | NCT07178639 | |
| Evaluation of Retinal Parameters in Patients With Epiretinal Membrane After Vitrectomy | eye disorder, macular degeneration, macular retinal edema, preretinal fibrosis, retinal degeneration, retinal disorder | Enrolling by invitation | Not applicable | 2025-09-10 | NCT07165626 | |
| Suprachoroidal Triamcinolone in Macular Edema for Patients With Non-Infectious Uveitis Resistant to Subtenon Triamcinolon | eye disorder, macular degeneration, macular retinal edema, retinal degeneration, retinal disorder | Recruiting | Early phase 1 | 2025-08-28 | NCT07145008 | |
| A Post-Authorization, Long-term Study of Ozanimod Real-world Safety | CNS demyelinating autoimmune disease, autoimmune disease, autoimmune disorder of the nervous system, demyelinating disease, eye disorder, immune system disorder, macular degeneration, macular retinal edema, multiple sclerosis, neoplasm, nervous system disorder, relapsing-remitting multiple sclerosis, retinal degeneration, retinal disorder | Active, not recruiting | Not stated | 2025-06-26 | NCT05605782 | |
| Minimal Vitrectomy Surgery for Epiretinal Membrane | eye disorder, macular degeneration, macular retinal edema, nuclear cataract, preretinal fibrosis, retinal degeneration, retinal disorder | Recruiting | Not applicable | 2025-06-13 | NCT07019896 | |
| Effect of Video Viewing on Intravitreal Injection Experience | Diabetes Complications, Embolism and Thrombosis, Metaplasia, Neovascularization, Pathologic, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Venous Thrombosis, age-related macular degeneration, cardiovascular disorder, choroidal neovascularization, diabetes mellitus, diabetic peripheral angiopathy, diabetic retinopathy, endocrine system disorder, eye disorder, macular degeneration, macular retinal edema, optic choroid disorder, retinal degeneration, retinal disorder, retinal vein occlusion, thrombotic disease, uveal disorder, vascular disorder | Recruiting | Not applicable | 2025-06-03 | NCT07002372 | |
| Multicenter Study on the Efficacy and Safety of OCS-01 in Subjects With Uveitis Related and Post Surgical Macular Edema | Irvine-Gass Syndrome, eye disorder, macular degeneration, macular retinal edema, retinal degeneration, retinal disorder, uveal disorder, uveitis | Active, not recruiting | Phase 2 | 2025-05-25 | NCT05608837 | |
| Intravitreal and Intracameral DEX in NPDR | background diabetic retinopathy, eye disorder, macular degeneration, macular retinal edema, retinal degeneration, retinal disorder | Enrolling by invitation | Phase 3 | 2025-04-30 | NCT06951087 | |
| Implementation of the Intravitreal Injection Administered by Nurses | Embolism and Thrombosis, Venous Thrombosis, cardiovascular disorder, diabetic macular edema, eye disorder, macular degeneration, macular retinal edema, retinal degeneration, retinal disorder, retinal vein occlusion, thrombotic disease, vascular disorder | Enrolling by invitation | Not stated | 2025-03-24 | NCT06511700 |